QGEN 42.09 (+3.16%)
NL0012169213Medical Diagnostics & ResearchDiagnostics & Research

Qiagen (QGEN) Stock Highlights

42.09 | +3.16%
2024-11-21 00:55:06
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The companys sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firms revenue (45% of 2021 sales), followed by EMEA (36%) and Asia-Pacific (19%).

Statistics

Range Today
40.49 42.42
Volume Today 1.86M
Range 1 Year
39.03 47.44
Volume 1 Year 288.15M
Range 3 Year
34.74 58
Volume 3 Year 761.55M
Range 10 Year
20.7277 59
Volume 10 Year 2.72B

Highlights

Market Capitalization 9.73B (mid)
Floating Shares 220.33M
Current Price 42.09
Price To Earnings 130.06
Price To Revenue 5.21
Price To Book 2.76
Earnings Per Share 0.34
Payout Ratio 0%

Performance

Latest +3.16%
1 Month -1.29%
3 Months -10.35%
6 Months -7.96%
1 Year +6.37%
3 Years -24.31%
5 Years +3.16%
10 Years +71.64%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.